Pathophysiology and Management of Diabetes: A Review

 

Vandna Dewangan*, Himanshu Pandey

Department of  Pharmacology, Columbia Institute of Pharmacy, Tekari, Near Vidhansabha, Raipur-493111(C.G.) India.

*Corresponding Author E-mail: vandnadewangan543@gmail.com

 

ABSTRACT:

Diabetes mellitus is a very common metabolic disorder of endocrine system, every year large Number of people suffered from diabetes. According to recent survey in India about 50.8 million people are suffered from diabetes in 2010, and it will rise to 87.0 million till 2030. For the management and prevention of type 1 and type 2 diabetes different approaches have been done throughout the time In this article we have briefly discuss about evaluation of anti-diabetic activity by the use of different in vivo methods including animal model and in vitro method with special reference to cell line techniques. Article also reflect the evaluation of various anti diabetics phytoconstituents which is obtain from different plant source their activity, mechanism of action and it also highlight the advancement that has been done in past few year by different scientist their work title in different beta cell line technique and what output come from their effort to understand diabetes and to overcome it.

 

KEYWORDS: Diabetes Mellitus, Pathophysiology, In-Vivo, In-Vitro Method, Treatment.

 

 


INTRODUCTION:

Diabetes is generally considered as chronic disorder of metabolism that affects the insulin production capacity of body. Insulin is hormones that can convert food in to energy which is also called glucose or sugar, insulin is released from Beta cell of pancreas to transport glucose into cell. [1]T.DUSO et.,al Sep 2014. Diabetes may be occurring due to either less production of insulin by beta cell of pancreas or due to cell not responding to the existing insulin [2] Z. Tao et.,al Sep2015diabetes is associated with Serious long-term complications which include heart diseases, stroke, foot ulcer, eye damage, disease related to kidney.[3] PA. Kumaret., al

 

Diabetes is mainly classified in three types:

Type1:

When the beta cell of pancreas is unable to produced sufficient amount of insulin which leads to insulin deficiency. Destruction of beta cell by auto immune attack by T cell is the primary cause of type1 diabetes it is also called insulin dependent diabetes mellitus. [4]JF. Munni et., al

 

Type2:

When insulin produced by beta cell is resist by cell, it is also called non-insulin dependent diabetes mellitus in type 2 diabetes cells not responded to the insulin produced by beta cell. [5] J. Riserus et., al Jan 2009

 

Type3:

Gestational diabetes occurs when pregnant women developed high blood sugar level without previous history. [2] Z. Tao et., al Sep 2015

 

Pathophysiology of Diabetes Mellitus:

Type -1 diabetes:

The major factor responsible for type-1 diabetes is autoimmune attack by T-antigen result in destruction of beat cell, which in turn result in insulin deficiency and less production of insulin. Various factors are there which triggered the autoimmune destruction of beta cell, such as environmental factor, genetic factor. Type-1 diabetes is generally occurring before age of 30 years. Individual suffering from type -1 diabetes has to take insulin from outside of body because his/her body is no longer able to produce insulin.[6] C. Archana et., al Type -1 diabetes also result in increase in ketone level because due to less insulin glucose could not enter into cell and thus remain into blood vessel ,due to which body fat is broken and release glycerol and free fatty acid through biolysis, this free fatty acid can be converted into ketone and which ultimately decrease concentration of hydrogen ion and also decrease level of electrolyte  thus cause dehydration and frequent urination which are common symptom of type -1  diabetes ,untreated ketoacidosis may result in death.[7] MH. Dawood et.,al 2015

 

Type-2 diabetes:

Unlike type -1 diabetes which may be due to autoimmune attack of Antigen on beta cell type-2 diabetes is mainly caused due to desensitization of cell, that means beta cell can produce sufficient amount of insulin but due to cellular resistance insulin is not used by cell. [2] Z. Tao et., al Sep 2015 Type -2 diabetes is characterized by 3 disorder (1) excess glucose production by liver (2) dysfunction in production of insulin by pancreases (3) peripheral resistance of insulin.

 

Major factor for insulin resistance is obesity, about 80% of people who suffered from type -2 diabetes have obesity problem, and ketoacidosis is generally not seen in type -2 diabetes because there is enough production of insulin to prevent ketone formation. [2] Z. Tao et.,al Sep 2015


 


Fig-1: Various steps involved in the occurrence of Diabetes

 


Management of Diabetes:

Treatment of diabetes is based on consideration of following points

 

Prevention:

About 80-90% of diabetes patients are suffering from type -2 diabetes, which is associated with obesity and overweight. Physical activity, eating healthy diet like protein and fiber rich diet which include whole grain, green vegetable, consumption of this can reduce the risk of type -2 diabetes, moreover less consumption of sugar rich food and less use of tobacco, smoking can also reduce diabetes risk.[8] HH. Kyu et., al[9] N. Demasi et., al[10] C. Willi et., al Dec.2007

 

Management:

Management of individual routine can be helpful in treatment of type -2 diabetes. Management of diet with less sugar consumption, involving in physical exercise and weight loss training should be recommended.[11] R. Saglam Belen et. ,al Jan 2015[12] N. Engl et., al Dec 2005[13][14] PR. Cavanagh et., al May 2004.


Medication:

Use of several medicines or anti hyper glycemic agent can be helpful in overcoming diabetes. In type-1 diabetes insulin injection is the only option. Type-2 can be treated with some drugs. Metformin is the choice of drug for type-2 diabetes to control blood sugar level. 02[5] J. Riserus et., al Jan 2009[15]AJ. Krentz et., al Feb 2005[16] J. Cheng et., al May 2014

 

Evaluation of Anti Diabetic Activity: 

Anti diabetic activity of any compound can be evaluated either by in vivo method or by in vitro techniques. In vivo method involve use of different experimental animal models while in vitro techniques can be use outside of body by using different cell line.

 

 

In vivo Methods:

Different animal models are used in evaluation of any compound. Rodents are generally used in diabetes evaluation like rat, mice. Rodents are given with different chemicals to induce diabetes, and then the animals are treated with test compound. Experiment is performed in groups of animals (Test group, treated group and controlled group etc.).[17] TS. Roopashree et., al Sep 2008 [18] BV. Ghule et., al Nov 2006

 

In-vitro techniques:

In vitro methods involve use of cell line techniques either obtained from mouse Insulinoma or from human beta cell for the evaluation of diabetes. Cell lines are basically the cell culture technique which is obtained from subculture of primary cell culture. Cell lines are sometime immortalized by inducing some carcinogenic mutation to the normal cell line.[17] TS. Roopashree et., al Sep 2008 [18] BV. Ghule et., al Nov 2006


 

Table :( 1) List of Animal models and Cell lines

S.N.

LIST OF ANIMAL MODEL’S

LIST OF CELL LINE’S

1.

2

3.

4.

5.

6.

Streptozotocin model of diabetes mellitus.

Alloxan model of diabetes mellitus.

Obese model of type-2 diabetes.

Zucker diabetic fatty rat.

Rodent model of diabetes mellitus.

Large mammals model (Dog and Rabbits).

MIN6, (cell origin Insulinoma,) species mouse.

CM, (cell origin Insulinoma), species human

BLOX5 (Cell origin, fetus pancreas), species human.

CC-1 (Cell of origin, liver) species rat

PANC-1(Cell origin, pancreases) species human

BRIN-BG5 (cell origin pancreatic islet) species rat.

 

 

 

Table: (2) List of Phytoconstituentsact as Anti-diabetic Agent

S.N.

SINTIFIC NAME/FAMILY

PHYTOCONSTITUENT

ACTIVITY

MECHANISM

1.

Acorus calamus (Acoraceae)

Phenylpropanoids, Sesquiterpenes, Flavones, Triterpenoid andsaponins

Ant diabetics

Decrease the activity of glucose-6 phosphate and fructose 1, 6phosphatases enzyme.

2.

Adina cordifolia (Rubiaceae)

Tannins, Saponins, and Flavonoids.

Ant diabetics

Increase the insulin secretion or inhibit the intestine absorption of glucose.

3.

Syzygium cumini (myrtaceae)

GlycosideJjamboline, Natural acid, Kaemferol, Myrecetin, Tannins.

Ant diabetics

Myricetin has been shown to improved GLUT-4express in both adipose tissue and skeletal muscles, Methanolic extract increase mRNA expression glucose transporter (GLUT-4)

4.

Andrographis paniculatanees  / Kalmegh (Acanthaceae)

Ditereneclactones, flavonoids.

Ant diabetics

A significant decrease in blood glucose level, hipoglysemic activity of Andrographis paniculata was reported.

 

 

 

 

Inhibition

5.

Camellia sinensis (Theaceae)

Caffeine and catechism.

Ant diabetics

Development of insulin resistance hypoglymia and other metabolic effect also decease glucose absorption from intestine.

6.

Momoradic charantia/ Karela (Cucurbitaceae)

Triterpene, steroid, alkaloid. Inorganic, lipid, and phenolic compound.

Ant diabetics

It decreases glucose oxidation and glucose uptake in liver decrease gluconeogenesis it also promotes lipid metabolism and fat reduction.

 

 

 

Table :( 3) List of past inventions using different Cell lines[19],PM. Dean et.,al July 1968 [20] AF. Gazdar et.,al Jan 1980 [21]A. Merglene et., al Feb 2004 [22] CB. Nwegard et., al Mar 1994

S.no.

Name of Scientists

Years

Title of work

Output

1.

Dean and Matthews

1968

Electrical activity of beta cell

This research give idea about the electrical condicity of cell, as a result insulin secreation is increase due to due to cyctoplasmicincrease in Calcium concentration.

2.

Gazdar and Santerre

1980,

1981

Immortalisation of beta cell

Beta cell can be immortalized by induction of tumor to pancreatic cell by irradiation or by virus, immortalized beta cellHave tendency to proliferate infinite time and thus in turn increase insulin secretion.

3.

Merglen

2004

Isolated clonal INS1E cells from the parenteral cells.

These cells display stable differentiated beta cell phenotype over 116 passages and are able to secrete insulin in response to elevated glucose concentrations. Their concentration-dependence curve is similar to that of rat islets.

4.

Newgard,

1994

Insulin-secreting cells of non-islet cell origin

Stable transfection of AtT-20 cells with a construct in which a viral promoter was used to direct expression of the human proinsulincDNA resulted in cell lines which secreted fully processed insulin. EAtT-20 cell line was engineered from ACTHsecreting cells of the anterior pituitary.

 


CONCLUSION:

Diabetes is a chronic metabolic disorder which is characterized by rise in blood glucose level, type 1 diabetes is due to low insulin secretion and type 2 diabetes is caused due to cell not responsive to the insulin. Prevention, management and proper treatment can reduce the risk of diabetes. Large number of herbs has been found to have ant diabetes property, phytochemical constituent of different plant can be evaluated for their ant diabetic property, they can either decrease glucose -6 phosphate activity or increase insulin secretion. Recent advancement in past few years in different pancreatic beta cell line provided the better understanding of the insulin secretion and thus promotes the treatment. in vivo models including different experimental animal and investor methods by use of different cell line derived either from mouse insulinoma or from human pancreatic cell. All this techniques provide the base for understanding the mechanism of diabetes and evaluation of ant diabetic activity and thus help to cure or overcome these diseases.

 

REFERENCES:

1.       Duso T, Herr A, Suppliet M. The Welfare Impact Of Parallel Imports: A Structural Approach Applied To The German Market For Oral AntiDiabetics. Health economics. 2014 Sep 1; 23(9):1036-57.

2.       Tao Z, Shi A, Zhao J. Epidemiological perspectives of diabetes. Cell biochemistry and biophysics. 2015 Sep 1; 73(1):181-5.

3.       Kumar PA, Sreedevi V. A Review On Influence Of Antidiabetic Medications On Quality Of Life.

4.       Munni JF. Impact of Chronic Diseases on Quality of Life (Doctoral dissertation, East West University).

5.       Risérus U, Willett WC, Hu FB. Dietary fats and prevention of type 2 diabetes. Progress in lipid research. 2009 Jan 31; 48(1):44-51.

6.       Archana C. A survey on Identification of Diabetes Mellitus Patients in Rural Area of Kouluru Village, Panyam Mandal, Kurnool district, Andhra Pradesh.

7.       Dawood MH. Comparison of serum alpha amylase level between type one and type two diabetes mellitus among Sudanese in Khartoum state in 2015 (Doctoral dissertation, Sudan University of Science and Technology).

8.       Kyu HH, Bachman VF, Alexander LT, Mumford JE, Afshin A, Estep K, Veerman JL, Delwiche K, Iannarone ML, Moyer ML, Cercy K. Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013. bmj. 2016 Aug 9; 354:i3857.

9.       DeMasi N. Developing a nutrition education website to increase nutrition knowledge and improve dietary behaviors among California State University, Northridge students (Doctoral dissertation, California State University, Northridge).

10.     Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. Jama. 2007 Dec 12; 298(22):2654-64.

11.     Belen Sağlam R, TaskayaTemizel T. A framework for automatic information quality ranking of diabetes websites. Informatics for Health and Social Care. 2015 Jan 2; 40(1):45-66.

12.     Diabetes Control and Complications Trial. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005 Dec 22;2005(353):2643-53.

13.     National Collaborating Centre for Chronic Conditions (Great Britain). Chronic kidney disease: national clinical guideline for early identification and management in adults in primary and secondary care. Royal College of Physicians.

14.     Cavanagh PR. Therapeutic footwear for people with diabetes. Diabetes/metabolism research and reviews. 2004 May 1;20(S1).

15.     Krentz AJ, Bailey CJ. Oral antidiabetic agents. Drugs. 2005 Feb 1;65(3):385-411.

16.     Cheng J, Zhang W, Zhang X, Han F, Li X, He X, Li Q, Chen J. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis. JAMA internal medicine. 2014 May 1;174(5):773-85.

17.     Roopashree TS, Dang R, Rani RS, Narendra C. Antibacterial activity of antipsoriatic herbs: Cassia tora, Momordica charantia and Calendula officinalis. International Journal of Applied Research in Natural Products. 2008 Sep 15;1(3):20-8.2008

18.     Ghule BV, Murugananthan G, Nakhat PD, Yeole PG. Immunostimulant effects of Cappariszeyl anica Linn. leaves. Journal of ethnopharmacology. 2006 Nov 24; 108(2):311-5.

19.     Dean PM, Matthews EK. Electrical activity in pancreatic islet cells. Nature. 1968 Jul 27; 219(5152):389-90.

20.     Gazdar AF, Chick WL, Oie HK, Sims HL, King DL, Weir GC, Lauris V. Continuous, clonal, insulin-and somatostatin-secreting cell lines established from a transplantable rat islet cell tumor. Proceedings of the National Academy of Sciences. 1980 Jun 1; 77(6):3519-23.

21.     Merglen A, Theander S, Rubi B, Chaffard G, Wollheim CB, Maechler P. Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells. Endocrinology. 2004 Feb 1; 145(2):667-78.

22.     Newgard CB. Cellular engineering and gene therapy strategies for insulin replacement in diabetes. Diabetes. 1994 Mar 1; 43(3):341-50

 

 

 

 

Received on 23.08.2016              Modified on 19.09.2016

Accepted on 15.10.2016             ©A&V Publications All right reserved

Res. J. Pharmacology & Pharmacodynamics.2016; 8(3): 219-222.

DOI: 10.5958/2321-5836.2017.00039.8